Table of Content

1 Insulin Sensitizers Market Overview
1.1 Product Overview and Scope of Insulin Sensitizers
1.2 Insulin Sensitizers Segment by Type
1.2.1 Global Insulin Sensitizers Market Value Comparison by Type (2024-2034)
1.2.2 Thiazolidinediones
1.2.3 Biguanides
1.2.4 Others
1.3 Insulin Sensitizers Segment by Application
1.3.1 Global Insulin Sensitizers Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Insulin Sensitizers Market Size Estimates and Forecasts
1.4.1 Global Insulin Sensitizers Revenue 2018-2029
1.4.2 Global Insulin Sensitizers Sales 2018-2029
1.4.3 Global Insulin Sensitizers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Insulin Sensitizers Market Competition by Manufacturers
2.1 Global Insulin Sensitizers Sales Market Share by Manufacturers (2018-2024)
2.2 Global Insulin Sensitizers Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Insulin Sensitizers Average Price by Manufacturers (2018-2024)
2.4 Global Insulin Sensitizers Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Insulin Sensitizers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Sensitizers, Product Type & Application
2.7 Insulin Sensitizers Market Competitive Situation and Trends
2.7.1 Insulin Sensitizers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Sensitizers Players Market Share by Revenue
2.7.3 Global Insulin Sensitizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Sensitizers Retrospective Market Scenario by Region
3.1 Global Insulin Sensitizers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Insulin Sensitizers Global Insulin Sensitizers Sales by Region: 2018-2029
3.2.1 Global Insulin Sensitizers Sales by Region: 2018-2024
3.2.2 Global Insulin Sensitizers Sales by Region: 2024-2029
3.3 Global Insulin Sensitizers Global Insulin Sensitizers Revenue by Region: 2018-2029
3.3.1 Global Insulin Sensitizers Revenue by Region: 2018-2024
3.3.2 Global Insulin Sensitizers Revenue by Region: 2024-2029
3.4 North America Insulin Sensitizers Market Facts & Figures by Country
3.4.1 North America Insulin Sensitizers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Insulin Sensitizers Sales by Country (2018-2029)
3.4.3 North America Insulin Sensitizers Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Sensitizers Market Facts & Figures by Country
3.5.1 Europe Insulin Sensitizers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Insulin Sensitizers Sales by Country (2018-2029)
3.5.3 Europe Insulin Sensitizers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Sensitizers Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Sensitizers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Insulin Sensitizers Sales by Country (2018-2029)
3.6.3 Asia Pacific Insulin Sensitizers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Sensitizers Market Facts & Figures by Country
3.7.1 Latin America Insulin Sensitizers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Insulin Sensitizers Sales by Country (2018-2029)
3.7.3 Latin America Insulin Sensitizers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Sensitizers Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Sensitizers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Insulin Sensitizers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Insulin Sensitizers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Sensitizers Sales by Type (2018-2029)
4.1.1 Global Insulin Sensitizers Sales by Type (2018-2024)
4.1.2 Global Insulin Sensitizers Sales by Type (2024-2029)
4.1.3 Global Insulin Sensitizers Sales Market Share by Type (2018-2029)
4.2 Global Insulin Sensitizers Revenue by Type (2018-2029)
4.2.1 Global Insulin Sensitizers Revenue by Type (2018-2024)
4.2.2 Global Insulin Sensitizers Revenue by Type (2024-2029)
4.2.3 Global Insulin Sensitizers Revenue Market Share by Type (2018-2029)
4.3 Global Insulin Sensitizers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Insulin Sensitizers Sales by Application (2018-2029)
5.1.1 Global Insulin Sensitizers Sales by Application (2018-2024)
5.1.2 Global Insulin Sensitizers Sales by Application (2024-2029)
5.1.3 Global Insulin Sensitizers Sales Market Share by Application (2018-2029)
5.2 Global Insulin Sensitizers Revenue by Application (2018-2029)
5.2.1 Global Insulin Sensitizers Revenue by Application (2018-2024)
5.2.2 Global Insulin Sensitizers Revenue by Application (2024-2029)
5.2.3 Global Insulin Sensitizers Revenue Market Share by Application (2018-2029)
5.3 Global Insulin Sensitizers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Insulin Sensitizers Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novo Nordisk Insulin Sensitizers Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Lilly
6.3.1 Lilly Corporation Information
6.3.2 Lilly Description and Business Overview
6.3.3 Lilly Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Lilly Insulin Sensitizers Product Portfolio
6.3.5 Lilly Recent Developments/Updates
6.4 MSD
6.4.1 MSD Corporation Information
6.4.2 MSD Description and Business Overview
6.4.3 MSD Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.4.4 MSD Insulin Sensitizers Product Portfolio
6.4.5 MSD Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Boehringer Ingelheim Insulin Sensitizers Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Chipscreen Biosciences
6.6.1 Chipscreen Biosciences Corporation Information
6.6.2 Chipscreen Biosciences Description and Business Overview
6.6.3 Chipscreen Biosciences Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Chipscreen Biosciences Insulin Sensitizers Product Portfolio
6.6.5 Chipscreen Biosciences Recent Developments/Updates
6.7 Shandong Lukang Pharmaceutical
6.6.1 Shandong Lukang Pharmaceutical Corporation Information
6.6.2 Shandong Lukang Pharmaceutical Description and Business Overview
6.6.3 Shandong Lukang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shandong Lukang Pharmaceutical Insulin Sensitizers Product Portfolio
6.7.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Hisun Pharmaceutical
6.8.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product Portfolio
6.8.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.9 SPH Zhongxi Pharmaceutical
6.9.1 SPH Zhongxi Pharmaceutical Corporation Information
6.9.2 SPH Zhongxi Pharmaceutical Description and Business Overview
6.9.3 SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.9.4 SPH Zhongxi Pharmaceutical Insulin Sensitizers Product Portfolio
6.9.5 SPH Zhongxi Pharmaceutical Recent Developments/Updates
6.10 Guizhou Shengjitang Pharmaceutical
6.10.1 Guizhou Shengjitang Pharmaceutical Corporation Information
6.10.2 Guizhou Shengjitang Pharmaceutical Description and Business Overview
6.10.3 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product Portfolio
6.10.5 Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
6.11 Chengdu Hengrui Pharmaceutical
6.11.1 Chengdu Hengrui Pharmaceutical Corporation Information
6.11.2 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Description and Business Overview
6.11.3 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product Portfolio
6.11.5 Chengdu Hengrui Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Wansheng Pharmaceutical
6.12.1 Zhejiang Wansheng Pharmaceutical Corporation Information
6.12.2 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Description and Business Overview
6.12.3 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product Portfolio
6.12.5 Zhejiang Wansheng Pharmaceutical Recent Developments/Updates
6.13 Shenzhen Neptunus Pharmaceutical
6.13.1 Shenzhen Neptunus Pharmaceutical Corporation Information
6.13.2 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Description and Business Overview
6.13.3 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product Portfolio
6.13.5 Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
6.14 Shanghai Kaibao Pharmaceutical
6.14.1 Shanghai Kaibao Pharmaceutical Corporation Information
6.14.2 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Description and Business Overview
6.14.3 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product Portfolio
6.14.5 Shanghai Kaibao Pharmaceutical Recent Developments/Updates
6.15 Hangzhou Conba Pharmaceutical
6.15.1 Hangzhou Conba Pharmaceutical Corporation Information
6.15.2 Hangzhou Conba Pharmaceutical Insulin Sensitizers Description and Business Overview
6.15.3 Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Hangzhou Conba Pharmaceutical Insulin Sensitizers Product Portfolio
6.15.5 Hangzhou Conba Pharmaceutical Recent Developments/Updates
6.16 Glaxosmithkline Pharmaceuticals
6.16.1 Glaxosmithkline Pharmaceuticals Corporation Information
6.16.2 Glaxosmithkline Pharmaceuticals Insulin Sensitizers Description and Business Overview
6.16.3 Glaxosmithkline Pharmaceuticals Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Glaxosmithkline Pharmaceuticals Insulin Sensitizers Product Portfolio
6.16.5 Glaxosmithkline Pharmaceuticals Recent Developments/Updates
6.17 Xian Taiji Pharmaceutical
6.17.1 Xian Taiji Pharmaceutical Corporation Information
6.17.2 Xian Taiji Pharmaceutical Insulin Sensitizers Description and Business Overview
6.17.3 Xian Taiji Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Xian Taiji Pharmaceutical Insulin Sensitizers Product Portfolio
6.17.5 Xian Taiji Pharmaceutical Recent Developments/Updates
6.18 Beijing Taiyang Pharmaceutical
6.18.1 Beijing Taiyang Pharmaceutical Corporation Information
6.18.2 Beijing Taiyang Pharmaceutical Insulin Sensitizers Description and Business Overview
6.18.3 Beijing Taiyang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Beijing Taiyang Pharmaceutical Insulin Sensitizers Product Portfolio
6.18.5 Beijing Taiyang Pharmaceutical Recent Developments/Updates
6.19 Shandong Zibo Xinda Pharmaceutical
6.19.1 Shandong Zibo Xinda Pharmaceutical Corporation Information
6.19.2 Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Description and Business Overview
6.19.3 Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Product Portfolio
6.19.5 Shandong Zibo Xinda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Sensitizers Industry Chain Analysis
7.2 Insulin Sensitizers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Sensitizers Production Mode & Process
7.4 Insulin Sensitizers Sales and Marketing
7.4.1 Insulin Sensitizers Sales Channels
7.4.2 Insulin Sensitizers Distributors
7.5 Insulin Sensitizers Customers
8 Insulin Sensitizers Market Dynamics
8.1 Insulin Sensitizers Industry Trends
8.2 Insulin Sensitizers Market Drivers
8.3 Insulin Sensitizers Market Challenges
8.4 Insulin Sensitizers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Insulin Sensitizers Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Insulin Sensitizers Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Insulin Sensitizers Market Competitive Situation by Manufacturers in 2022
Table 4. Global Insulin Sensitizers Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Insulin Sensitizers Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Insulin Sensitizers Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Insulin Sensitizers Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Insulin Sensitizers Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Insulin Sensitizers, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Insulin Sensitizers, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Sensitizers, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Sensitizers, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Sensitizers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Sensitizers as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Sensitizers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Insulin Sensitizers Sales by Region (2018-2024) & (K Units)
Table 18. Global Insulin Sensitizers Sales Market Share by Region (2018-2024)
Table 19. Global Insulin Sensitizers Sales by Region (2024-2029) & (K Units)
Table 20. Global Insulin Sensitizers Sales Market Share by Region (2024-2029)
Table 21. Global Insulin Sensitizers Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Insulin Sensitizers Revenue Market Share by Region (2018-2024)
Table 23. Global Insulin Sensitizers Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Insulin Sensitizers Revenue Market Share by Region (2024-2029)
Table 25. North America Insulin Sensitizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Insulin Sensitizers Sales by Country (2018-2024) & (K Units)
Table 27. North America Insulin Sensitizers Sales by Country (2024-2029) & (K Units)
Table 28. North America Insulin Sensitizers Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Insulin Sensitizers Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Insulin Sensitizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Insulin Sensitizers Sales by Country (2018-2024) & (K Units)
Table 32. Europe Insulin Sensitizers Sales by Country (2024-2029) & (K Units)
Table 33. Europe Insulin Sensitizers Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Insulin Sensitizers Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Insulin Sensitizers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Insulin Sensitizers Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Insulin Sensitizers Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Insulin Sensitizers Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Sensitizers Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Insulin Sensitizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Insulin Sensitizers Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Insulin Sensitizers Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Insulin Sensitizers Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Insulin Sensitizers Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Insulin Sensitizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Insulin Sensitizers Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Insulin Sensitizers Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Insulin Sensitizers Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Sensitizers Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Insulin Sensitizers Sales (K Units) by Type (2018-2024)
Table 51. Global Insulin Sensitizers Sales (K Units) by Type (2024-2029)
Table 52. Global Insulin Sensitizers Sales Market Share by Type (2018-2024)
Table 53. Global Insulin Sensitizers Sales Market Share by Type (2024-2029)
Table 54. Global Insulin Sensitizers Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Insulin Sensitizers Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Insulin Sensitizers Revenue Market Share by Type (2018-2024)
Table 57. Global Insulin Sensitizers Revenue Market Share by Type (2024-2029)
Table 58. Global Insulin Sensitizers Price (US$/Unit) by Type (2018-2024)
Table 59. Global Insulin Sensitizers Price (US$/Unit) by Type (2024-2029)
Table 60. Global Insulin Sensitizers Sales (K Units) by Application (2018-2024)
Table 61. Global Insulin Sensitizers Sales (K Units) by Application (2024-2029)
Table 62. Global Insulin Sensitizers Sales Market Share by Application (2018-2024)
Table 63. Global Insulin Sensitizers Sales Market Share by Application (2024-2029)
Table 64. Global Insulin Sensitizers Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Insulin Sensitizers Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Insulin Sensitizers Revenue Market Share by Application (2018-2024)
Table 67. Global Insulin Sensitizers Revenue Market Share by Application (2024-2029)
Table 68. Global Insulin Sensitizers Price (US$/Unit) by Application (2018-2024)
Table 69. Global Insulin Sensitizers Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Insulin Sensitizers Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Novo Nordisk Insulin Sensitizers Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Lilly Corporation Information
Table 81. Lilly Description and Business Overview
Table 82. Lilly Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Lilly Insulin Sensitizers Product
Table 84. Lilly Recent Developments/Updates
Table 85. MSD Corporation Information
Table 86. MSD Description and Business Overview
Table 87. MSD Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. MSD Insulin Sensitizers Product
Table 89. MSD Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Boehringer Ingelheim Insulin Sensitizers Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Chipscreen Biosciences Corporation Information
Table 96. Chipscreen Biosciences Description and Business Overview
Table 97. Chipscreen Biosciences Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Chipscreen Biosciences Insulin Sensitizers Product
Table 99. Chipscreen Biosciences Recent Developments/Updates
Table 100. Shandong Lukang Pharmaceutical Corporation Information
Table 101. Shandong Lukang Pharmaceutical Description and Business Overview
Table 102. Shandong Lukang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Shandong Lukang Pharmaceutical Insulin Sensitizers Product
Table 104. Shandong Lukang Pharmaceutical Recent Developments/Updates
Table 105. Zhejiang Hisun Pharmaceutical Corporation Information
Table 106. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 107. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product
Table 109. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 110. SPH Zhongxi Pharmaceutical Corporation Information
Table 111. SPH Zhongxi Pharmaceutical Description and Business Overview
Table 112. SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. SPH Zhongxi Pharmaceutical Insulin Sensitizers Product
Table 114. SPH Zhongxi Pharmaceutical Recent Developments/Updates
Table 115. Guizhou Shengjitang Pharmaceutical Corporation Information
Table 116. Guizhou Shengjitang Pharmaceutical Description and Business Overview
Table 117. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product
Table 119. Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
Table 120. Chengdu Hengrui Pharmaceutical Corporation Information
Table 121. Chengdu Hengrui Pharmaceutical Description and Business Overview
Table 122. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product
Table 124. Chengdu Hengrui Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Wansheng Pharmaceutical Corporation Information
Table 126. Zhejiang Wansheng Pharmaceutical Description and Business Overview
Table 127. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product
Table 129. Zhejiang Wansheng Pharmaceutical Recent Developments/Updates
Table 130. Shenzhen Neptunus Pharmaceutical Corporation Information
Table 131. Shenzhen Neptunus Pharmaceutical Description and Business Overview
Table 132. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product
Table 134. Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
Table 135. Shanghai Kaibao Pharmaceutical Corporation Information
Table 136. Shanghai Kaibao Pharmaceutical Description and Business Overview
Table 137. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product
Table 139. Shanghai Kaibao Pharmaceutical Recent Developments/Updates
Table 140. Hangzhou Conba Pharmaceutical Corporation Information
Table 141. Hangzhou Conba Pharmaceutical Description and Business Overview
Table 142. Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Hangzhou Conba Pharmaceutical Insulin Sensitizers Product
Table 144. Hangzhou Conba Pharmaceutical Recent Developments/Updates
Table 145. Glaxosmithkline Pharmaceuticals Corporation Information
Table 146. Glaxosmithkline Pharmaceuticals Description and Business Overview
Table 147. Glaxosmithkline Pharmaceuticals Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Glaxosmithkline Pharmaceuticals Insulin Sensitizers Product
Table 149. Glaxosmithkline Pharmaceuticals Recent Developments/Updates
Table 150. Xian Taiji Pharmaceutical Corporation Information
Table 151. Xian Taiji Pharmaceutical Description and Business Overview
Table 152. Xian Taiji Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Xian Taiji Pharmaceutical Insulin Sensitizers Product
Table 154. Xian Taiji Pharmaceutical Recent Developments/Updates
Table 155. Beijing Taiyang Pharmaceutical Corporation Information
Table 156. Beijing Taiyang Pharmaceutical Description and Business Overview
Table 157. Beijing Taiyang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Beijing Taiyang Pharmaceutical Insulin Sensitizers Product
Table 159. Beijing Taiyang Pharmaceutical Recent Developments/Updates
Table 160. Shandong Zibo Xinda Pharmaceutical Corporation Information
Table 161. Shandong Zibo Xinda Pharmaceutical Description and Business Overview
Table 162. Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Product
Table 164. Shandong Zibo Xinda Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Insulin Sensitizers Distributors List
Table 168. Insulin Sensitizers Customers List
Table 169. Insulin Sensitizers Market Trends
Table 170. Insulin Sensitizers Market Drivers
Table 171. Insulin Sensitizers Market Challenges
Table 172. Insulin Sensitizers Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Sensitizers
Figure 2. Global Insulin Sensitizers Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Insulin Sensitizers Market Share by Type in 2022 & 2029
Figure 4. Thiazolidinediones Product Picture
Figure 5. Biguanides Product Picture
Figure 6. Others Product Picture
Figure 7. Global Insulin Sensitizers Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Insulin Sensitizers Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Drugstore
Figure 11. Global Insulin Sensitizers Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Insulin Sensitizers Market Size (2018-2029) & (US$ Million)
Figure 13. Global Insulin Sensitizers Sales (2018-2029) & (K Units)
Figure 14. Global Insulin Sensitizers Average Price (US$/Unit) & (2018-2029)
Figure 15. Insulin Sensitizers Report Years Considered
Figure 16. Insulin Sensitizers Sales Share by Manufacturers in 2022
Figure 17. Global Insulin Sensitizers Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Insulin Sensitizers Players: Market Share by Revenue in 2022
Figure 19. Insulin Sensitizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Insulin Sensitizers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Insulin Sensitizers Sales Market Share by Country (2018-2029)
Figure 22. North America Insulin Sensitizers Revenue Market Share by Country (2018-2029)
Figure 23. United States Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Insulin Sensitizers Sales Market Share by Country (2018-2029)
Figure 26. Europe Insulin Sensitizers Revenue Market Share by Country (2018-2029)
Figure 27. Germany Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Insulin Sensitizers Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Insulin Sensitizers Revenue Market Share by Region (2018-2029)
Figure 34. China Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Insulin Sensitizers Sales Market Share by Country (2018-2029)
Figure 42. Latin America Insulin Sensitizers Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Insulin Sensitizers Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Insulin Sensitizers Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Insulin Sensitizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Insulin Sensitizers by Type (2018-2029)
Figure 52. Global Revenue Market Share of Insulin Sensitizers by Type (2018-2029)
Figure 53. Global Insulin Sensitizers Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Insulin Sensitizers by Application (2018-2029)
Figure 55. Global Revenue Market Share of Insulin Sensitizers by Application (2018-2029)
Figure 56. Global Insulin Sensitizers Price (US$/Unit) by Application (2018-2029)
Figure 57. Insulin Sensitizers Value Chain
Figure 58. Insulin Sensitizers Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed